Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023

敗血症診断の世界市場予測(~2023年):技術別、製品別、方法別、検査種類別、病原体別、エンドユーザー別、地域別分析

◆タイトル:Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023
◆商品コード:MAM-MD-4575
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年4月5日
◆ページ数:194
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥632,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥744,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥912,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、敗血症診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品別分析、方法別分析、検査種類別分析、敗血症診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The sepsis diagnostics market projected to grow at a CAGR of 9.1%.”The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. Rising incidence of sepsis, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and commercialization and availability of a wide variety of approved sepsis diagnostic devices are the factors expected to drive the market during the study period. However, the lack of established reimbursement policies for sepsis and high cost of automated diagnostic devices are the major factors restraining the growth of this market.

“Microbiology to command the largest share of the sepsis diagnostics market in 2018.”
On the basis of technology, the microbiology segment is expected to command the largest share of the global sepsis diagnostics market in 2018. The large share of this segment can be attributed to the growing use of blood culture techniques for the diagnosis of sepsis.

“The blood culture media segment is expected to be the fastest-growing segment during the forecast period.”
On the basis of products, the market is segmented into blood culture media, instruments, assays & reagents, and software. The blood culture media segment is expected to be the fastest-growing segment during the forecast period. The large share of this segment can be attributed to the fact that blood culture testing is used as the standard diagnostic method for the diagnosis and identification of sepsis across the globe.

“Asia Pacific is expected grow at the highest CAGR during the forecast period.”
Geographically, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period due to the high prevalence of sepsis, increasing number of surgical procedures, growing number of clinical studies, and developing healthcare infrastructure in this region.

Breakdown of supply-side primary interviews:
• By Company Type – Tier 1 – 30%, Tier 2 – 55% and Tier 3 – 15%
• By Designation – C-level – 30%, Director-level – 35%, Others – 35%
• By Region – North America – 55%, Europe – 15%, APAC – 25%, RoW – 5%

The major players of the sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).

Research Coverage

This report studies the sepsis diagnostics market based on technology, product, pathogen, test type, method, end user, and region. The report studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends. The research report forecasts the revenue of market segments with respect to the four key regions and respective countries.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis— market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.4 MARKETS COVERED 19
1.4.1 YEARS CONSIDERED FOR THE STUDY 20
1.5 CURRENCY 20
1.6 LIMITATIONS 20
1.7 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 22
2.1.1.1 Key data from secondary sources 23
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 24
2.1.2.2 Key industry insights 25
2.1.3 MARKET SIZE ESTIMATION METHODOLOGY 25
2.1.4 BOTTOM-UP APPROACH 26
2.1.5 TOP-DOWN APPROACH 26
2.1.6 RESEARCH DESIGN 28
2.1.7 MARKET DATA VALIDATION AND TRIANGULATION 29
2.1.8 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 SEPSIS DIAGNOSTICS: MARKET OVERVIEW 36
4.2 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 37
4.3 GEOGRAPHIC ANALYSIS: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT AND REGION 38
4.4 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN 38
4.5 SEPSIS DIAGNOSTICS MARKET, BY METHOD 39
4.6 GEOGRAPHIC SNAPSHOT OF THE SEPSIS DIAGNOSTICS MARKET 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42

5.2.1.1 High incidence of sepsis in the adult population 42
5.2.1.1 Increasing incidence of sepsis in neonates 43
5.2.1.2 Growing incidence of hospital-acquired infections 44
5.2.1.3 Increasing number of surgical procedures 44
5.2.1.4 Increasing burden of pneumonia 45
5.2.1.5 Influx of novel sepsis diagnostic products 45
5.2.1.6 Rising initiatives to increase the awareness and drive the adoption of sepsis diagnostic tests 46
5.2.1.7 Funding for sepsis-related research activities 47
5.2.2 RESTRAINTS 47
5.2.2.1 Lack of established reimbursement policies for sepsis 47
5.2.2.2 High cost of automated diagnostic devices 48
5.2.3 OPPORTUNITIES 48
5.2.3.1 Development of rapid diagnostic/POC techniques for early sepsis diagnosis 48
5.2.3.2 Evolution of novel biomarkers for sepsis diagnosis 49
5.2.4 CHALLENGES 49
5.2.4.1 Lack of standard protocols and awareness for sepsis diagnosis and treatment 49
5.2.4.2 Shortage of skilled healthcare professionals 50
6 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 51
6.1 INTRODUCTION 52
6.2 MICROBIOLOGY 53
6.3 MOLECULAR DIAGNOSTICS 54
6.3.1 POLYMERASE CHAIN REACTION 54
6.3.2 PEPTIDE NUCLEIC ACID-FLUORESCENT IN SITU HYBRIDIZATION 54
6.3.3 MICROARRAYS 55
6.3.4 SYNDROMIC PANEL-BASED TESTING 55
6.4 IMMUNOASSAY 56
6.5 FLOW CYTOMETRY 57
6.6 MICROFLUIDICS 58
6.7 BIOMARKERS 59
7 SEPSIS DIAGNOSTICS MARKET, BY PRODUCT 60
7.1 INTRODUCTION 61
7.2 INSTRUMENTS 62
7.3 BLOOD CULTURE MEDIA 63
7.4 ASSAYS & REAGENTS 64
7.5 SOFTWARE 65

8 SEPSIS DIAGNOSTICS MARKET, BY METHOD 67
8.1 INTRODUCTION 68
8.2 CONVENTIONAL DIAGNOSTICS 69
8.3 AUTOMATED DIAGNOSTICS 70
9 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN 72
9.1 INTRODUCTION 73
9.2 BACTERIAL SEPSIS 74
9.2.1 GRAM-NEGATIVE BACTERIAL SEPSIS 75
9.2.2 GRAM-POSITIVE BACTERIAL SEPSIS 76
9.3 FUNGAL SEPSIS 76
9.4 OTHER PATHOGENS 77
10 SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE 79
10.1 INTRODUCTION 80
10.2 LABORATORY TESTS 81
10.3 POINT-OF-CARE TESTS 82
11 SEPSIS DIAGNOSTICS MARKET, BY END USER 85
11.1 INTRODUCTION 86
11.2 HOSPITALS 87
11.3 PATHOLOGY & REFERENCE LABORATORIES 88
12 SEPSIS DIAGNOSTICS MARKET, BY REGION 89
12.1 INTRODUCTION 90
12.2 NORTH AMERICA 92
12.2.1 US 95
12.2.2 CANADA 99
12.3 EUROPE 103
12.3.1 GERMANY 106
12.3.2 FRANCE 109
12.3.3 UK 112
12.3.4 REST OF EUROPE (ROE) 115
12.4 ASIA PACIFIC 119
12.4.1 JAPAN 122
12.4.2 CHINA 125
12.4.3 INDIA 128
12.4.4 REST OF ASIA PACIFIC 131
12.5 REST OF THE WORLD 134
12.5.1 LATIN AMERICA 137
12.5.2 MIDDLE EAST & AFRICA 140
13 COMPETITIVE LANDSCAPE 143
13.1 OVERVIEW 143
13.2 MARKET SHARE ANALYSIS 144
13.3 COMPETITIVE SCENARIO 145
13.3.1 PRODUCT LAUNCHES AND APPROVALS, 2015–2017 145
13.3.2 PARTNERSHIPS AND COLLABORATIONS, 2015–2018 145
13.3.3 MERGERS AND ACQUISITIONS 146
14 COMPANY PROFILES 147
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 BIOMÉRIEUX 147
14.2 T2 BIOSYSTEMS 151
14.3 LUMINEX 153
14.4 BECTON, DICKINSON, AND COMPANY (BD) 156
14.5 ROCHE DIAGNOSTICS (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.) 158
14.6 DANAHER 161
14.7 THERMO FISHER SCIENTIFIC 165
14.8 BRUKER 168
14.9 ABBOTT 171
14.10 IMMUNEXPRESS 173
14.11 RESPONSE BIOMEDICAL 175
14.12 AXIS-SHIELD DIAGNOSTICS 176
14.13 CYTOSORBENTS 177
14.14 MITSUBISHI CHEMICAL EUROPE 180
14.15 EKF DIAGNOSTICS 181
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX 183
15.1 DISCUSSION GUIDE 183
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 188
15.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 190
15.4 AVAILABLE CUSTOMIZATIONS 192
15.5 RELATED REPORTS 192
15.6 AUTHOR DETAILS 193

LIST OF TABLES

TABLE 1 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 52
TABLE 2 MICROBIOLOGY MARKET FOR SEPSIS DIAGNOSIS, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 3 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSIS, BY REGION,
2016–2023 (USD MILLION) 55
TABLE 4 IMMUNOASSAY MARKET FOR SEPSIS DIAGNOSIS, BY REGION,
2016–2023 (USD MILLION) 56
TABLE 5 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSIS, BY REGION,
2016–2023 (USD MILLION) 57
TABLE 6 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSIS, BY REGION,
2016–2023 (USD MILLION) 58
TABLE 7 BIOMARKERS MARKET FOR SEPSIS DIAGNOSIS, BY REGION,
2016–2023 (USD MILLION) 59
TABLE 8 SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 61
TABLE 9 SEPSIS DIAGNOSTIC INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 63
TABLE 10 SEPSIS DIAGNOSTIC BLOOD CULTURE MEDIA MARKET, BY REGION,
2016–2023 (USD MILLION) 64
TABLE 11 SEPSIS DIAGNOSTIC ASSAYS & REAGENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 65
TABLE 12 SEPSIS DIAGNOSTIC SOFTWARE MARKET, BY REGION, 2016–2023 (USD MILLION) 66
TABLE 13 SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 68
TABLE 14 CONVENTIONAL DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 70
TABLE 15 AUTOMATED DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 71
TABLE 16 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 73
TABLE 17 BACTERIAL SEPSIS MARKET, BY TYPE, 2016–2023 (USD MILLION) 74
TABLE 18 BACTERIAL SEPSIS MARKET, BY REGION, 2016–2023 (USD MILLION) 74
TABLE 19 BACTERIAL CAUSES OF ADULT SEPSIS 75
TABLE 20 BACTERIAL CAUSES OF ADULT SEPSIS 76
TABLE 21 FUNGAL SEPSIS MARKET, BY REGION, 2016–2023 (USD MILLION) 77
TABLE 22 OTHER PATHOGENS MARKET, BY REGION, 2016–2023 (USD MILLION) 78
TABLE 23 SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 80
TABLE 24 LABORATORY POINTERS OF SEPSIS 81
TABLE 25 LABORATORY TESTS MARKET, BY REGION, 2016–2023 (USD MILLION) 82
TABLE 26 POINT-OF-CARE TESTS MARKET, BY REGION, 2016-2023 (USD MILLION) 84
TABLE 27 SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 86
TABLE 28 SEPSIS DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION,
2016–2023 (USD MILLION) 87
TABLE 29 SEPSIS DIAGNOSTICS MARKET FOR PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 88
TABLE 30 SEPSIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 91
TABLE 31 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 93
TABLE 32 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 93
TABLE 33 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 94
TABLE 34 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN,
2016–2023 (USD MILLION) 94
TABLE 35 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD,
2016–2023 (USD MILLION) 94
TABLE 36 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 95
TABLE 37 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 95
TABLE 38 US: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 97
TABLE 39 US: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 97
TABLE 40 US: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 98
TABLE 41 US: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 98
TABLE 42 US: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 98
TABLE 43 US: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 99
TABLE 44 CANADA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 100
TABLE 45 CANADA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 101
TABLE 46 CANADA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN,
2016–2023 (USD MILLION) 101
TABLE 47 CANADA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 101
TABLE 48 CANADA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 102
TABLE 49 CANADA: SEPSIS DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 102
TABLE 50 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 104
TABLE 51 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 104
TABLE 52 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 104
TABLE 53 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN,
2016–2023 (USD MILLION) 105
TABLE 54 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 105
TABLE 55 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 105
TABLE 56 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 106
TABLE 57 GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 107
TABLE 58 GERMANY: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 108
TABLE 59 GERMANY: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN,
2016–2023 (USD MILLION) 108
TABLE 60 GERMANY: SEPSIS DIAGNOSTICS MARKET, BY METHOD,
2016–2023 (USD MILLION) 108
TABLE 61 GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 109
TABLE 62 GERMANY: SEPSIS DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 109
TABLE 63 FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 110
TABLE 64 FRANCE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 110
TABLE 65 FRANCE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN,
2016–2023 (USD MILLION) 111
TABLE 66 FRANCE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 111
TABLE 67 FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 111
TABLE 68 FRANCE: SEPSIS DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 112
TABLE 69 UK: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 113
TABLE 70 UK: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 113
TABLE 71 UK: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 114
TABLE 72 UK: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 114
TABLE 73 UK: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 114
TABLE 74 UK: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 115
TABLE 75 ROE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 116
TABLE 76 ROE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 117
TABLE 77 ROE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 117
TABLE 78 ROE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 117
TABLE 79 ROE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 118
TABLE 80 ROE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 118
TABLE 81 APAC: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 120
TABLE 82 APAC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 120
TABLE 83 APAC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 120
TABLE 84 APAC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 121
TABLE 85 APAC: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 121
TABLE 86 APAC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 121
TABLE 87 APAC: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 122
TABLE 88 JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 123
TABLE 89 JAPAN: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 123
TABLE 90 JAPAN: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 123
TABLE 91 JAPAN: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 124
TABLE 92 JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 124
TABLE 93 JAPAN: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 124
TABLE 94 CHINA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 126
TABLE 95 CHINA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 126
TABLE 96 CHINA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 126
TABLE 97 CHINA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 127
TABLE 98 CHINA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 127
TABLE 99 CHINA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 127
TABLE 100 INDIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 129
TABLE 101 INDIA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 129
TABLE 102 INDIA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 130
TABLE 103 INDIA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 130
TABLE 104 INDIA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 130
TABLE 105 INDIA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 131
TABLE 106 ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 132
TABLE 107 ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 133
TABLE 108 ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN,
2016–2023 (USD MILLION) 133
TABLE 109 ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 133
TABLE 110 ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 134
TABLE 111 ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 134
TABLE 112 ROW: SEPSIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 134
TABLE 113 ROW: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 135
TABLE 114 ROW: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 135
TABLE 115 ROW: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016–2023 (USD MILLION) 135
TABLE 116 ROW: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016–2023 (USD MILLION) 136
TABLE 117 ROW: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 136
TABLE 118 ROW: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 136
TABLE 119 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 138
TABLE 120 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 138
TABLE 121 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN,
2016–2023 (USD MILLION) 138
TABLE 122 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD,
2016–2023 (USD MILLION) 139
TABLE 123 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 139
TABLE 124 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 139
TABLE 125 MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 141
TABLE 126 MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 141

TABLE 127 MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN,
2016–2023 (USD MILLION) 141
TABLE 128 MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD,
2016–2023 (USD MILLION) 142
TABLE 129 MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 142
TABLE 130 MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 142


LIST OF FIGURES

FIGURE 1 GLOBAL SEPSIS DIAGNOSTICS MARKET: RESEARCH METHODOLOGY STEPS 21
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 24
FIGURE 3 DATA TRIANGULATION METHODOLOGY 29
FIGURE 4 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2018 31
FIGURE 5 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023 32
FIGURE 6 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2018 32
FIGURE 7 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2018 VS. 2023 33
FIGURE 8 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2018 33
FIGURE 9 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY END USER, 2018 34
FIGURE 10 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, 2018 (USD MILLION) 35
FIGURE 11 RISING PREVALENCE OF SEPSIS IS DRIVING THE GROWTH OF SEPSIS DIAGNOSTICS MARKET ACROSS THE GLOBE 36
FIGURE 12 MICROBIOLOGY SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2023 37
FIGURE 13 BLOOD CULTURE MEDIA SEGMENT TO DOMINATE THE GLOBAL SEPSIS DIAGNOSTICS PRODUCTS MARKET IN 2018 38
FIGURE 14 BACTERIAL SEPSIS SEGMENT TO DOMINATE THE SEPSIS DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 38
FIGURE 15 CONVENTIONAL DIAGNOSTICS METHOD TO DOMINATE THE SEPSIS DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 39
FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 39
FIGURE 17 SEPSIS DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
FIGURE 18 BIOMARKERS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 52
FIGURE 19 BLOOD CULTURE MEDIA SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 61
FIGURE 20 CONVENTIONAL DIAGNOSTICS SEGMENT TO DOMINATE THE SEPSIS DIAGNOSTICS MARKET IN 2023 68
FIGURE 21 BACTERIAL SEPSIS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 73
FIGURE 22 POINT-OF-CARE TESTS SEGMENT TO GROW AT THE HIGHEST CAGR 80
FIGURE 23 HOSPITALS SEGMENT TO DOMINATE THE SEPSIS DIAGNOSTICS MARKET IN 2023 86
FIGURE 24 SEPSIS INCIDENCE, BY COUNTRY, 2017 90
FIGURE 25 SEPSIS DIAGNOSTICS MARKET: GROWTH FORECAST, BY REGION (2018–2023) 91
FIGURE 26 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET SNAPSHOT 92
FIGURE 27 EUROPE: SEPSIS DIAGNOSTICS MARKET SNAPSHOT 103
FIGURE 28 APAC: SEPSIS DIAGNOSTICS MARKET SNAPSHOT 119
FIGURE 29 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE SEPSIS DIAGNOSTICS MARKET, 2015–2017 143
FIGURE 30 SEPSIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYERS, 2016 144
FIGURE 31 BIOMÉRIEUX: COMPANY SNAPSHOT 148
FIGURE 32 T2 BIOSYSTEMS: COMPANY SNAPSHOT 151
FIGURE 33 LUMINEX: COMPANY SNAPSHOT 153
FIGURE 34 BD: COMPANY SNAPSHOT 156
FIGURE 35 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 158
FIGURE 36 DANAHER: COMPANY SNAPSHOT 161
FIGURE 37 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 165
FIGURE 38 BRUKER: COMPANY SNAPSHOT 168
FIGURE 39 ABBOTT: COMPANY SNAPSHOT 171
FIGURE 40 CYTOSORBENTS: COMPANY SNAPSHOT 177
FIGURE 41 EKF DIAGNOSTICS: COMPANY SNAPSHOT 181


【レポートのキーワード】

敗血症診断、敗血症検査

★調査レポート[敗血症診断の世界市場予測(~2023年):技術別、製品別、方法別、検査種類別、病原体別、エンドユーザー別、地域別分析] ( Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023 / MAM-MD-4575) 販売に関する免責事項
[敗血症診断の世界市場予測(~2023年):技術別、製品別、方法別、検査種類別、病原体別、エンドユーザー別、地域別分析] ( Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023 / MAM-MD-4575) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆